Nom |
disulfate de butirosine |
Synonymes |
Sulfate de butirosine anhydre [USAN] ; Sulfate de butirosine ; Sulfate d’ambutyrosine ; Sulfate de butirosine anhydre ; sulfate de butirosine ; Sulfate de butirosine anhydre ; Butirosine, sulfate (sel) ; CL 642 ; D-Streptamine, O-2,6-diamino-2,6-didésoxy-alpha-D-glucopyranosyl-(1-4)-O-(bêta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-désoxy-, (S)-, sulfate (1 :2) (sel) dihydraté avec O-2,6-diamino-2,6-didésoxy-alpha-D-glucopyranosyl-(1-4)-O-(bêta-D-ribofuranosyl-(1-5))-N(sup 1)-((S)-4-amino-2-hydroxy-1-oxobutyl)-2-désoxy-D-sulfate de streptamine (1 :2) (sel) anhydre ; Mélange dihydraté d’O-2,6-diamino-2,6-didésoxy-alpha-D-glucopyranosyl-(1-4)-O-(bêta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-désoxy-D-streptamine sulfate (1 :2) (sel) dihydraté avec O-2,6-diamino-2,6-didésoxy-alpha-D-glucopyranosyl-(1-4)-O-(bêta-D-ribofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-désoxy-D-sulfate de streptamine (1 :2) (sel) anhydre ; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-didésoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-[(3xi)-bêta-D-érythro-pentofuranosyloxy]cyclohexyl}-2-hydroxybutanamide sulfate hydraté (1 :2 :2) ; 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-didésoxy-L-érythro-hexopyranosyl)oxy]-2-hydroxy-3-(D-lyxofuranosyloxy)cyclohexyl]-2-hydroxybutanamide disulfate (sel) |
Nom anglais |
butirosin disulfate;Butirosin sulfate anhydrous [USAN]; Butirosin sulfate; Ambutyrosin sulfate; Butirosin sulfate anhydrous; Butirosin sulphate; Butirosin sulphate anhydrous; Butirosin, sulfate (salt); CL 642; D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-((S)-4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; O-2,6-Diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-xylofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) dihydrate mixture with O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(beta-D-ribofuranosyl-(1-5))-N(sup 1)-(4-amino-L-2-hydroxybutyryl)-2-deoxy-D-streptamine sulfate (1:2) (salt) anhydrous; 4-amino-N-{(1R,2S,3R,4R,5S)-5-amino-4-[(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxy-3-[(3xi)-beta-D-erythro-pentofuranosyloxy]cyclohexyl}-2-hydroxybutanamide sulfate hydrate (1:2:2); 4-amino-N-[(2R,3R)-5-amino-4-[(2,6-diamino-2,6-dideoxy-L-erythro-hexopyranosyl)oxy]-2-hydroxy-3-(D-lyxofuranosyloxy)cyclohexyl]-2-hydroxybutanamide disulfate (salt) |
Formule moléculaire |
C21H45N5O20S2 |
Poids Moléculaire |
751.7335 |
InChI |
InChI=1/C21H41N5O12.2H2O4S/c22-2-1-8(28)19(34)26-7-3-6(24)17(37-20-11(25)15(32)13(30)9(4-23)35-20)18(12(7)29)38-21-16(33)14(31)10(5-27)36-21;2*1-5(2,3)4/h6-18,20-21,27-33H,1-5,22-25H2,(H,26,34);2*(H2,1,2,3,4)/t6?,7?,8?,9?,10-,11+,12-,13?,14+,15-,16+,17?,18-,20?,21?;;/m1../s1 |
Numéro de registre CAS |
51022-98-1 |
Structure moléculaire |
|
Point d'ébullition |
947.4°C at 760 mmHg |
Point d'éclair |
526.8°C |
Pression de vapeur |
0mmHg at 25°C |
Les symboles de danger |
|
Codes des risques |
|
Description de sécurité |
|
|